SECOND SIGHT MEDICAL PRODUCT (EYES)
US81362J3086 - Common Stock
| TTM (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -9.07M | -8.92M | -14.88M | -33.59M | -35.09M | |||
| Depreciation Amortization | 62.00K | 70.00K | 164.00K | 397.00K | 435.00K | |||
| Change In Working Capital | -473.00K | -421.00K | -3.74M | 37.00K | 425.00K | |||
| Interest Paid | N/A | 135.00K | N/A | N/A | N/A | |||
| Other non cash items | 61.00K | 84.00K | 1.64M | 5.53M | 4.42M | |||
| OPERATING CASH FLOW | -9.42M | -9.19M | -16.82M | -27.63M | -29.81M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -32.00K | -14.00K | -330.00K | -493.00K | -163.00K | |||
| Other Investing Activity | N/A | 0.00 | 398.00K | N/A | N/A | |||
| INVESTING CASH FLOW | -8.03M | -14.00K | 68.00K | -493.00K | -163.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -2.20M | 2.20M | N/A | N/A | |||
| Stock Issued/Repurchased | 0.00 | 77.81M | 6.40M | 34.99M | 26.60M | |||
| Other Financing Activity | N/A | 2.00K | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 2.00K | 75.62M | 8.60M | 34.99M | 26.60M | |||
| Exchange Rate Effect | -16.00K | 2.00K | 6.00K | -11.00K | 4.00K | |||
| CHANGE IN CASH | -17.47M | 66.42M | -8.15M | 6.86M | -3.37M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -9.42M | -9.19M | -16.82M | -27.63M | -29.81M | |||
| Capital Expenditure | -32.00K | -14.00K | -330.00K | -493.00K | -163.00K | |||
| FREE CASH FLOW | -9.45M | -9.20M | -17.15M | -28.12M | -29.97M | |||
All data in USD